tiprankstipranks
Trending News
More News >
Sugi Holdings Co Ltd (JP:7649)
:7649
Advertisement

Sugi Holdings Co (7649) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7649

Sugi Holdings Co

(OTC:7649)

Rating:75Outperform
Price Target:
¥4,094.00
▲(11.58%Upside)
Sugi Holdings Co's strong financial performance is the key driver of its overall stock score, showcasing growth, profitability, and financial stability. Technical analysis supports a bullish trend, although overbought indicators suggest caution. The valuation presents a fair investment opportunity, though not exceptionally attractive. The absence of recent earnings call insights or corporate events leaves the financial and technical analyses as the primary influences.

Sugi Holdings Co (7649) vs. iShares MSCI Japan ETF (EWJ)

Sugi Holdings Co Business Overview & Revenue Model

Company DescriptionSugi Holdings Co.,Ltd. operates drugstores in Japan. It also provides visiting nursing services and home care support services. As of June 1, 2019, the company operated 1,190 stores. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
How the Company Makes MoneySugi Holdings Co., Ltd. generates revenue primarily through the sale of pharmaceutical products, over-the-counter drugs, and a diverse range of health and beauty items. The company's pharmacies are strategically located to serve a broad customer base, providing both prescription fulfillment services and retail sales. Revenue streams are bolstered by its ability to attract repeat customers through loyalty programs and personalized healthcare services. Additionally, Sugi Holdings benefits from economies of scale and strong supplier relationships, which contribute to its profitability. The company also explores opportunities for expansion and diversification to drive growth, including partnerships with healthcare providers and leveraging technology to enhance customer experience.

Sugi Holdings Co Financial Statement Overview

Summary
Sugi Holdings Co exhibits a solid financial performance across all key areas. The income statement indicates strong growth and profitability, supported by efficient operations. The balance sheet reflects financial stability with a conservative debt profile. Cash flow analysis shows robust liquidity and strong cash generation. Overall, the company is well-positioned for continued growth and stability, with minimal financial risk.
Income Statement
85
Very Positive
Sugi Holdings Co has demonstrated strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit margin and net profit margin have been stable, reflecting efficient cost management. EBIT and EBITDA margins are healthy, suggesting robust operational performance. The company's consistent revenue growth trajectory is a positive sign for future profitability.
Balance Sheet
78
Positive
The company's balance sheet reflects a strong equity position with a stable debt-to-equity ratio, indicating a conservative leverage strategy. The equity ratio is healthy, suggesting a solid financial foundation. However, there was a minor increase in total liabilities, which should be monitored for potential risks. Overall, the balance sheet suggests financial stability and low financial risk.
Cash Flow
80
Positive
Sugi Holdings Co has shown a strong free cash flow growth rate, indicating improved cash generation capabilities. The operating cash flow to net income ratio is stable, reflecting efficient cash management. The company has maintained a positive free cash flow to net income ratio, highlighting its ability to generate cash relative to its profitability. Cash flow trends suggest robust liquidity and financial flexibility.
BreakdownMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue878.02B744.48B667.65B625.48B602.51B
Gross Profit275.04B228.84B202.52B191.49B181.29B
EBITDA56.18B46.24B44.02B43.41B43.64B
Net Income25.69B21.98B19.01B19.39B21.12B
Balance Sheet
Total Assets495.12B390.56B351.89B334.76B345.93B
Cash, Cash Equivalents and Short-Term Investments52.79B47.43B70.64B71.83B95.84B
Total Debt45.35B837.00M1.95B2.31B2.33B
Total Liabilities244.41B157.20B135.36B120.87B145.30B
Stockholders Equity250.70B233.36B216.54B213.89B200.63B
Cash Flow
Free Cash Flow13.31B6.34B16.77B-16.20B12.46B
Operating Cash Flow36.94B39.04B38.28B7.17B34.03B
Investing Cash Flow-33.28B-30.98B-23.26B-23.89B-29.25B
Financing Cash Flow11.63B-5.28B-14.21B-5.29B-5.27B

Sugi Holdings Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3669.00
Price Trends
50DMA
3276.16
Positive
100DMA
3079.36
Positive
200DMA
2827.30
Positive
Market Momentum
MACD
141.09
Negative
RSI
66.70
Neutral
STOCH
86.43
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7649, the sentiment is Positive. The current price of 3669 is above the 20-day moving average (MA) of 3465.15, above the 50-day MA of 3276.16, and above the 200-day MA of 2827.30, indicating a bullish trend. The MACD of 141.09 indicates Negative momentum. The RSI at 66.70 is Neutral, neither overbought nor oversold. The STOCH value of 86.43 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7649.

Sugi Holdings Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$691.52B16.1516.26%0.95%20.18%82.36%
52
Neutral
kr5.53B10.86-63.86%2.05%27.22%26.17%
$3.66B18.0711.61%2.68%
$3.80B18.714.93%3.29%
76
Outperform
¥423.01B22.95
0.35%14.79%35.84%
74
Outperform
¥540.15B29.43
1.39%7.43%-24.81%
70
Neutral
¥729.21B23.44
0.76%6.96%18.31%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7649
Sugi Holdings Co
3,669.00
1,262.22
52.44%
SDGCF
Sundrug Co
31.10
5.66
22.25%
TSUSF
TSURUHA Holdings
55.00
-1.72
-3.03%
JP:3141
Welcia Holdings Co., Ltd.
2,599.50
690.10
36.14%
JP:3349
COSMOS Pharmaceutical Corporation
9,161.00
2,781.60
43.60%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,965.00
951.46
31.57%

Sugi Holdings Co Corporate Events

Sugi Holdings Reports Strong Sales Growth in June 2025
Jul 15, 2025

Sugi Holdings Co., Ltd. reported a 4.7% increase in sales for existing stores in June 2025, with the drugstore business growing by 2.9% and the prescription business by 11.8%. On an all-store basis, sales rose by 17.0%, driven by a 6.9% increase in the drugstore segment and a significant 57.6% rise in prescription sales. The company opened 8 new stores and closed 10, resulting in a total of 2,204 stores by the end of June, reflecting its strategic adjustments in the market.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Revises Financial Forecasts Upward Amid Strong Sales
Jul 10, 2025

Sugi Holdings Co., Ltd. has revised its financial forecasts for the fiscal year ending February 2026, following increased sales in the first quarter and the recording of additional deferred tax assets. The upward revision reflects a positive outlook on net sales, operating profit, and ordinary profit, driven by a merger within its subsidiaries and a strategic focus on capturing market demand.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Sugi Holdings Reports Strong Financial Growth for Q1 2025
Jul 10, 2025

Sugi Holdings Co., Ltd. reported a significant increase in its financial performance for the three months ended May 31, 2025, with net sales rising by 22.1% and profit attributable to owners of the parent increasing by 246.6% compared to the previous year. The company also revised its consolidated earnings forecast for the fiscal year ending February 28, 2026, reflecting a positive outlook despite the exclusion of I&H Co., Ltd. following an absorption-type merger with Sugi Pharmacy Co., Ltd.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Completes Treasury Stock Disposition
Jun 13, 2025

SUGI Holdings Co., Ltd. has completed the payment procedures for the disposition of treasury stock as restricted stock remuneration, a decision made by its Board of Directors on May 27, 2025. This move involves the distribution of 7,044 shares of common stock to various directors and executive officers, amounting to a total disposition value of 22,195,644 yen, potentially impacting the company’s financial strategy and stakeholder interests.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Maintains Independence Amid Significant Shareholder Ownership
May 30, 2025

SUGI Holdings Co., Ltd. has disclosed information regarding Sugi Shoji Co., Ltd., which holds 37.43% of its voting rights. Despite this significant ownership, Sugi Shoji does not impose any restrictions on SUGI Holdings’ business activities, and there are no plans to change this arrangement, ensuring stability in the company’s operations and management.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

SUGI Holdings Announces Treasury Stock Disposition for Executive Incentives
May 27, 2025

SUGI Holdings Co., Ltd. has announced a resolution to dispose of 7,044 shares of its treasury stock as part of its restricted stock remuneration system. This initiative aims to incentivize directors and executive officers to enhance corporate value and align their interests with shareholders. The move is expected to strengthen the company’s governance and motivate key personnel by tying their compensation to the company’s stock performance.

The most recent analyst rating on (JP:7649) stock is a Hold with a Yen2850.00 price target. To see the full list of analyst forecasts on Sugi Holdings Co stock, see the JP:7649 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 12, 2025